Molecules That Target Nucleophosmin for Cancer Treatment: an Update
Overview
Authors
Affiliations
Nucleophosmin is a highly and ubiquitously expressed protein, mainly localized in nucleoli but able to shuttle between nucleus and cytoplasm. Nucleophosmin plays crucial roles in ribosome maturation and export, centrosome duplication, cell cycle progression, histone assembly and response to a variety of stress stimuli. Much interest in this protein has arisen in the past ten years, since the discovery of heterozygous mutations in the terminal exon of the NPM1 gene, which are the most frequent genetic alteration in acute myeloid leukemia. Nucleophosmin is also frequently overexpressed in solid tumours and, in many cases, its overexpression correlates with mitotic index and metastatization. Therefore it is considered as a promising target for the treatment of both haematologic and solid malignancies. NPM1 targeting molecules may suppress different functions of the protein, interfere with its subcellular localization, with its oligomerization properties or drive its degradation. In the recent years, several such molecules have been described and here we review what is currently known about them, their interaction with nucleophosmin and the mechanistic basis of their toxicity. Collectively, these molecules exemplify a number of different strategies that can be adopted to target nucleophosmin and we summarize them at the end of the review.
Abnormalities in Chromosomes 5 and 7 in Myelodysplastic Syndrome and Acute Myeloid Leukemia.
Kendrick T, Buic D, Fuller K, Erber W Ann Lab Med. 2025; 45(2):133-145.
PMID: 39774131 PMC: 11788707. DOI: 10.3343/alm.2024.0477.
Jang H, Min H, Kang Y, Boo H, Kim J, Ahn J Nat Commun. 2024; 15(1):4909.
PMID: 38851766 PMC: 11162468. DOI: 10.1038/s41467-024-49199-9.
Algar S, Vazquez-Villa H, Aguilar-Garrido P, Navarro-Aguadero M, Velasco-Estevez M, Sanchez-Merino A JACS Au. 2024; 4(5):1786-1800.
PMID: 38818079 PMC: 11134387. DOI: 10.1021/jacsau.3c00682.
Suh Y, Lee J, George J, Seol D, Jeong K, Oh S Br J Cancer. 2024; 130(9):1571-1584.
PMID: 38467827 PMC: 11059174. DOI: 10.1038/s41416-024-02642-6.
Ding X, Zhu X, Xu D, Li S, Yang Q, Feng X Cell Death Dis. 2023; 14(8):575.
PMID: 37648688 PMC: 10469196. DOI: 10.1038/s41419-023-06043-0.